Latest filing published 10 Jan 2018 for InMed Pharmaceuticals Inc., €157k.
Filing timeline
BuySaleInsider track record
Jeff Charpentier: trading record in brief
Jeff Charpentier discloses dealings in InMed Pharmaceuticals Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 12 December 2016 to 10 January 2018.
The open-market record consists of 1 sale worth €157k, with no purchase. Other entries cover 1 option exercise. In 2018 alone, the filings show no purchases and 1 sale.
On 10 January 2018 came the latest disclosure, an open-market sale for €157k in InMed Pharmaceuticals Inc. Most trades are made public on the day they happen. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeff Charpentier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 140,000 shares@ CA$1.671492.3% of flowCommon SharesTSXSEDI:3116450
- 140,000 shares@ CA$0.147.7% of flowCommon SharesTSXSEDI:3116437
- Common SharesTSXSEDI:3116433
3 of 3 declarations
